### The STEP 5 Study: Long-Term Adherence The STEP 5 two-year extension study (*Nature Medicine*, 2022) showed: - Patients who maintained consistent dosing for 2 years sustained an average weight loss of 15.2% - Adherence was the strongest predictor of long-term success - Patients who missed occasional doses (but did not discontinue) still achieved meaningful results - The difference between "perfect" adherence and "good" adherence (missing 12 doses per quarter) was relatively small **Key takeaway**: Don't panic about occasional missed doses
For tissue homogenates, 5 g total protein were used and the results normalized to amount of total input protein and expressed as ng GPX3/g protein
Given that most of the 510(k) device categories (product codes) and original predicates date back to 1976, the De Novo pathway provides an opportunity to update and modernize the list of regulatory device categories available to both manufacturers and regulators
Current practice Although authoritative health and medical entities recommend comprehensive lifestyle modification as part of the treatment plan for obesity, the use of such therapies before or to support GLP-1 use is not widespread in practice
On the measurable dimensions that matter most for results concentration, dual-peptide formulation, clinical trial size, delivery method, and guarantee length Hairgenetix leads across every category
[cited 2023 November 23]
